Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Ultrasound contrast agent
Patent
1995-05-22
1997-09-23
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Ultrasound contrast agent
514 54, 514 56, 514 57, 514 60, 424646, 424648, A61B 813
Patent
active
056701357
ABSTRACT:
A method of contrast enhanced ultrasonic diagnostic imaging comprising: administering to a subject a contrast enhancing amount of spheres or particles comprising a matrix enclosing a contrast agent which reflects sound waves, said matrix being a biocompatible, biodegradable, non-immunogenic non-polyamino acid synthetic polymer; and generating an ultrasonic image of said subject.
REFERENCES:
patent: 3663687 (1972-05-01), Evans
patent: 3720761 (1973-03-01), Hunter
patent: 3832457 (1974-08-01), Sugimoto et al.
patent: 3932805 (1976-01-01), Abe et al.
patent: 4101435 (1978-07-01), Hasegawa et al.
patent: 4247406 (1981-01-01), Widder et al.
patent: 4265251 (1981-05-01), Tickner
patent: 4276885 (1981-07-01), Tickner
patent: 4331654 (1982-05-01), Morris
patent: 4442843 (1984-04-01), Rasor et al.
patent: 4452773 (1984-06-01), Molday
patent: 4501726 (1985-02-01), Schroder et al.
patent: 4544545 (1985-10-01), Ryan
patent: 4572203 (1986-02-01), Feinstein
patent: 4615879 (1986-10-01), Runge et al.
patent: 4657756 (1987-04-01), Rasor et al.
patent: 4681119 (1987-07-01), Rasor et al.
patent: 4718433 (1988-01-01), Feinstein
patent: 4774958 (1988-10-01), Feinstein
patent: 4827945 (1989-05-01), Groman et al.
patent: 4900540 (1990-02-01), Ryan et al.
patent: 5141738 (1992-08-01), Rasor et al.
Abe et al., "Development Procedure of Magnetic Focusing Method for NMR Medical Application," vol. 2, No. 1, pp. 1-23, 1984.
Cox et al., J. Pharm. Pharmac., 24, 1972, 513-517.
Ohgushi et al., Journal of Magnetic Resonance, 29, 1978, 599-601.
Tanaka et al., Sogo Rinsho, 30:2609-2614, 1981, translated.
Tanaka et al., Proceedings of the IEEE, 66:1582-1583, 1978, translated.
Newton et al., Eds., Modern Neuroradiology, vol. two, Advanced Imaging Techniques, 1983, p. 97.
Nakamura et al., J. Applied Physics, 42, 4, 1971, p. 1320.
Perry, "A Survey of Ferromagnetic Liquid Applications," 1977, pp. 219-230.
Newbower, IEEE Transactions on Magnetics, vol. Mag. 9, No. 3, Sep. 1973, pp. 447-450.
Merck, 1985, p. 269, "Polyamid".
NMR Imaging in Biomedicine, Mansfield and Morris, Supp. 2, Advances in Magnetic Resonance, 1982, p. 234.
Runge et al., Radiology, 147, 3, Jun. 1983, p. 789 (Abstract).
Stark et al., Radiology, Sep. 1983, "Nuclear Magnetic Resonance Imaging of Experimentally Induced Liver Disease", pp. 743-750.
Becker, High Resolution NMR, Theory and Chemical Applications, 2nd Edition, 1980, p. 97.
Runge et al., Intl. J. Nucl. Med. Bull., 12, 1, 1985, 37-42, "Particulate Oral NMR Contrast Agents".
Hollinden Gary E.
Nycomed Imaging AS
LandOfFree
Ultrasonic contrast agent comprising carbohydrate particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ultrasonic contrast agent comprising carbohydrate particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ultrasonic contrast agent comprising carbohydrate particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1937816